Swiss Medical Network Science & Innovation

Science and innovation are central to Swiss Medical Network’s activities. Investment in quality research is essential to ensure that diagnostic methods are constantly improved and that the most innovative and safest therapeutic solutions are implemented.

Science & Innovation

Swiss Medical Network has consolidated its research activity by creating Science & Innovation.

The activities of this new scientific platform are divided into four main areas:

  • The development of clinical and translational research programmes;
  • The promotion of conventions with the academic world and Swiss and international research institutions;
  • The strengthening of fundraising policies;
  • The scaling up of continuous training and exchanges in the field of education
<h2>A world first</h2>

<p>The Clinique Générale-Beaulieu's Radixact tomotherapy (the only tomotherapy radiotherapy equipment in Geneva) will now be fully controlled by Raysearch's RayCare. Considered a pioneer, the Clinique Générale-Beaulieu is the first clinic in the world to have fully integrated and used RayCare.</p>

A world first

The Clinique Générale-Beaulieu's Radixact tomotherapy (the only tomotherapy radiotherapy equipment in Geneva) will now be fully controlled by Raysearch's RayCare. Considered a pioneer, the Clinique Générale-Beaulieu is the first clinic in the world to have fully integrated and used RayCare.

Research programmes

Science & Innovation has decided to focus on several key areas: orthopaedics, oncology and ophthalmology to name a few.

Orthopaedics

Professor Guido Garavaglia, Head of Teaching and Research at Clinica Ars Medica, Gravesano, and Professor at the Faculty of Medicine, University of Geneva, developed an IT platform for the implementation of systematic PROM (Patient-Reported Outcome Measures) data collection for all types of clinical activities. 

Read more

Oncology

Dr Matti Aapro (Clinique de Genolier) published a large number of peer-reviewed articles in various domains of medical oncology. His numerous research programs in geriatric oncology, breast cancer management and supportive care bear witness to his experience in clinical research protocols and educational activities

Read more

Ophthalmology

“With over 95 scientific publications since 2018, the Swiss Visio Montchoisi Glaucoma Research Centre has quickly become one of the most active centres in Switzerland (and one of the three most active centres in Europe) in this field.” Prof. K. Mansouri

Read more

Scientific reports

Swiss Medical Network publishes an annual scientific report, presenting the strategies and operational aspects of the research carried out by the Group’s clinics, whether in the context of clinical research developed internally or in the context of programmes carried out in collaboration with external Swiss or international institutions or networks.

Scientific Report 2021

Scientific Report 2020

Scientific Report 2019

 

Strong collaborations in Switzerland and abroad

Swiss Medical Network’s clinical research programmes are conducted in close collaboration with leading organisations. In Switzerland, these include:

  • The Lausanne University Hospital (CHUV)
  • AGORA: Flagship of the Swiss Cancer Center Léman (SCCL)
  • The Geneva University Hospitals (HUG)
  • The French-speaking oncology network
  • The Swiss Federal Institute of Technology in Zurich (ETHZ)
  • The Swiss Cancer Clinical Research Group (SAKK)
  • The Biopôle in Lausanne
  • The SITEM StartUp Club in Bern

On an international scale, the Group works with the European Organisation for Research and Treatment of Cancer (EORTC) and academic institutions based in New York and Houston.

<h2>“Training at the cutting edge of innovation” with Lea Sprunger</h2>

<p>Lea Sprunger, European champion of the 400-metre hurdles, manages her health capital at the Clinique de Genolier.</p>

“Training at the cutting edge of innovation” with Lea Sprunger

Lea Sprunger, European champion of the 400-metre hurdles, manages her health capital at the Clinique de Genolier.

Dr. Méd. Jacques Bernier, Chief Science Officer Science & Innovation de SwissMedical Network

Specialist in Radio-Oncology and Nuclear Medicine from the University of Liège in Belgium, Jacques Bernier is the Swiss Medical Network’s Chief Science Officer. From 2006 till 2019, he is Head of the Radiation Oncology Department at the Clinique de Genolier and Medical Director of Centre d’Oncologie des Eaux-Vives in Geneva.

In 2010, he is awarded the “Claudius Regaud Medal” by the European Society of Therapeutic Radiology and Oncology - ESTRO. From 2016 till 2019, he is President of the Euro-Asian Society of Mastology – EURAMA, based in Milan. He also chairs the Genolier Cancer Center till 2019.

Ask your questions about the programme

News

Opening of the physical therapy center in Bulle

Endometriosis - the chameleon of gynaecology

Opening of the physical therapy center in Bulle

A complete success: The first public lecture of 2023

Giornata mondiale contro il cancro - 04.02.2023

Première implantation d'un microstent Hydrus en Suisse

Events

Medical conference

Conferenza medica "Dolore vertebrale"

Public event

Blue March

Medical conference

Symposium annuel d'ophtalmologie

Find out more

About us

Medical infrastructure

Quality management

Philosophy

Management

Board of Directors